Ravindra Chandrashekhar, MD
Sleep Medicine · Carrollton, TXNPI 1245422955
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 54.6% of the total. Reporting peaked in 2022 at $508 and has fallen 70.4% since, to $150 in 2025. That places this record below the midpoint for sleep medicine clinicians in TX, where the typical reported total is $1,720.
Across 14 payments — averaging $98.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$753
- Avadel CNS Pharmaceuticals, LLC$150
- ZOLL Respicardia, Inc.$144
- Gilead$125
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$98
- AstraZeneca$64
- plus $46 from 2 others
What the payments were for
- Food & beverage$1,379100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 7 | $753 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $150 |
| ZOLL Respicardia, Inc. | 1 | $144 |
| Gilead | 1 | $125 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $98 |
| AstraZeneca | 1 | $64 |
| Itamar Medical Inc | 1 | $32 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XYWAV$626
- LUMRYZ$150
- remede System$144
- Veklury$125
How this compares
$1,379 in reported general payments places this provider in the 40th percentile of 112 sleep medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Losartan Potassium | 12 | $28 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Carrollton
- Gerard MeskillSugar Land$1M
- Vikas JainFrisco$673K
- Amit VermaHouston$493K
- Jerald SimmonsHouston$165K
- James AndrySan Antonio$100K
- William BurkesBeaumont$99K
- Ashwin GowdaAustin$71K
- John DebusDallas$38K
- Peter ObessoTyler$34K
- Karen Hentschel FranksSan Antonio$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.